Article
Effects of the sigma-1 receptor agonist blarcamesine in a murine model of fragile X syndrome: neurobehavioral phenotypes and receptor occupancy.
Scientific reports - 25 Aug 2021
Reyes Samantha T, Deacon Robert M J, Guo Scarlett G, Altimiras Francisco J, Castillo Jessa B, van der Wildt Berend, Morales Aimara P, Park Jun Hyung, Klamer Daniel, Rosenberg Jarrett, Oberman Lindsay M, Rebowe Nell, Sprouse Jeffrey, Missling Christopher U, McCurdy Christopher R, Cogram Patricia, Kaufmann Walter E, Chin Frederick T
Abstract excerpt
Fragile X syndrome (FXS), a disorder of synaptic development and function, is the most prevalent genetic form of intellectual disability and autism spectrum disorder. FXS mouse models display clinically-relevant phenotypes, such as increased anxiety and hyperactivity. Despite their availability, so far advances in drug development have not yielded new treatments. Therefore, testing novel drugs that can ameliorate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
